Thorac Cardiovasc Surg 2021; 69(06): 504-510
DOI: 10.1055/s-0040-1713351
Original Cardiovascular

Successful Heart Transplantation after Cardiopulmonary Resuscitation of Donors

Arash Mehdiani*
1   Department of Cardiac Surgery, University Hospital Duesseldorf, Duesseldorf, Germany
,
Moritz Benjamin Immohr*
1   Department of Cardiac Surgery, University Hospital Duesseldorf, Duesseldorf, Germany
,
Nihat Firat Sipahi
1   Department of Cardiac Surgery, University Hospital Duesseldorf, Duesseldorf, Germany
,
Charlotte Boettger
1   Department of Cardiac Surgery, University Hospital Duesseldorf, Duesseldorf, Germany
,
Hannan Dalyanoglu
1   Department of Cardiac Surgery, University Hospital Duesseldorf, Duesseldorf, Germany
,
Daniel Scheiber
2   Department of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University Medical School, Moorenstrasse 5, Duesseldorf, Germany
,
Ralf Westenfeld
2   Department of Cardiology, Pulmonology and Vascular Medicine, Heinrich-Heine-University Medical School, Moorenstrasse 5, Duesseldorf, Germany
,
1   Department of Cardiac Surgery, University Hospital Duesseldorf, Duesseldorf, Germany
,
Artur Lichtenberg
1   Department of Cardiac Surgery, University Hospital Duesseldorf, Duesseldorf, Germany
,
1   Department of Cardiac Surgery, University Hospital Duesseldorf, Duesseldorf, Germany
,
1   Department of Cardiac Surgery, University Hospital Duesseldorf, Duesseldorf, Germany
› Author Affiliations

Abstract

Background Heart transplantation (HTx) is the best therapy for end-stage heart failure. Unfortunately, death on the waiting list remains a problem. Decreasing the number of rejected organs could increase the donor pool.

Methods A total of 144 patients underwent HTx at our department between 2010 and 2019. Of them, 27 patients received organs of donors with cardiopulmonary resuscitation (CPR) prior to organ donation (donor CPR) and were compared with patients who received organs without CPR (control; n = 117).

Results We did not observe any disadvantage in the outcome of the donor CPR group compared with the control group. Postoperative morbidity and 1-year survival (control: 72%; donor CPR: 82%; p = 0.35) did not show any differences. We found no impact of the CPR time as well as the duration between CPR and organ donation, but we found an improved survival rate for donors suffering from anoxic brain injury compared with cerebral injury (p = 0.04).

Conclusions Donor organs should not be rejected for HTx due to resuscitation prior to donation. The need for CPR does not affect the graft function after HTx in both short- and mid-term outcomes. We encourage the use of these organs to increase the donor pool and preserve good results.

* Both authors share first authorship.




Publication History

Received: 29 December 2019

Accepted: 27 April 2020

Article published online:
16 July 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Khush KK, Cherikh WS, Chambers DC. et al; International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report-2018; Focus Theme: Multiorgan Transplantation. J Heart Lung Transplant 2018; 37 (10) 1155-1168
  • 2 Eurotransplant International Foundation. Annual Report 2018. Accessed on July 15, 2019 https://www.eurotransplant.org/wp-content/uploads/2019/12/032675-_ET_Jaarverslag_2018_v7-1.pdf
  • 3 Fuchs M, Schibilsky D, Zeh W, Berchtold-Herz M, Beyersdorf F, Siepe M. Does the heart transplant have a future?. Eur J Cardiothorac Surg 2019; 55 (Suppl. 01) i38-i48
  • 4 Wittwer T, Wahlers T. Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience. Transpl Int 2008; 21 (02) 113-125
  • 5 Khush KK. Donor selection in the modern era. Ann Cardiothorac Surg 2018; 7 (01) 126-134
  • 6 Pilarczyk K, Osswald BR, Pizanis N. et al. Use of donors who have suffered cardiopulmonary arrest and resuscitation in lung transplantation. Eur J Cardiothorac Surg 2011; 39 (03) 342-347
  • 7 Matsumoto CS, Kaufman SS, Girlanda R. et al. Utilization of donors who have suffered cardiopulmonary arrest and resuscitation in intestinal transplantation. Transplantation 2008; 86 (07) 941-946
  • 8 Galeone A, Varnous S, Lebreton G. et al. Impact of cardiac arrest resuscitated donors on heart transplant recipients' outcome. J Thorac Cardiovasc Surg 2017; 153 (03) 622-630
  • 9 Jentzer JC, Chonde MD, Dezfulian C. Myocardial dysfunction and shock after cardiac arrest. BioMed Res Int 2015; 2015: 314796
  • 10 Southerland KW, Castleberry AW, Williams JB, Daneshmand MA, Ali AA, Milano CA. Impact of donor cardiac arrest on heart transplantation. Surgery 2013; 154 (02) 312-319
  • 11 Quader MA, Wolfe LG, Kasirajan V. Heart transplantation outcomes from cardiac arrest-resuscitated donors. J Heart Lung Transplant 2013; 32 (11) 1090-1095
  • 12 Cheng A, Schumer EM, Trivedi JR, Van Berkel VH, Massey HT, Slaughter MS. Does donor cardiopulmonary resuscitation time affect heart transplantation outcomes and survival?. Ann Thorac Surg 2016; 102 (03) 751-758
  • 13 Ivey-Stephenson AZ, Crosby AE, Jack SPD, Haileyesus T, Kresnow-Sedacca MJ. Suicide trends among and within urbanization levels by sex, race/ethnicity, age group, and mechanism of death - United States, 2001-2015. MMWR Surveill Summ 2017; 66 (18) 1-16
  • 14 Nicoara A, Ruffin D, Cooter M. et al. Primary graft dysfunction after heart transplantation: incidence, trends, and associated risk factors. Am J Transplant 2018; 18 (06) 1461-1470
  • 15 Kobashigawa J, Khush K, Colvin M. et al. Report from the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States. Am J Transplant 2017; 17 (10) 2559-2566
  • 16 Patil KD, Halperin HR, Becker LB. Cardiac arrest: resuscitation and reperfusion. Circ Res 2015; 116 (12) 2041-2049
  • 17 Totsuka E, Fung JJ, Urakami A. et al. Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning. Hepatology 2000; 31 (03) 577-580
  • 18 Ganesh JS, Rogers CA, Banner NR, Bonser RS. Donor cause of death and medium-term survival after heart transplantation: a United Kingdom national study. J Thorac Cardiovasc Surg 2005; 129 (05) 1153-1159
  • 19 Davis AM, Natelson BH. Brain-heart interactions. The neurocardiology of arrhythmia and sudden cardiac death. Tex Heart Inst J 1993; 20 (03) 158-169